Article ID Journal Published Year Pages File Type
2082714 Drug Discovery Today: Technologies 2006 9 Pages PDF
Abstract

The application of diversity selection for identification of biologically active molecules is based on the similarity property principle according to which no compound similar to a compound already in the screening needs to be screened since a similar outcome can be expected. However, experimental errors of the screening experiment and the only limited validity of the similarity property principle can lead to the situation that a diversely selected subset does not cover more hit series of a screening summary data set than a random selection. Due to the size bias in chemical similarity functions diversely selected subset can have a reduced complexity, which causes unwanted side effects on the distribution of IC50 values.

Section editors:Tudor Oprea – University of New Mexico School of Medicine, Albuquerque, USAAlex Tropsha – University of North Carolina, Chapel Hill, USA

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology
Authors
, ,